TABLE 2.
Baseline characteristics of patients receiving plasma exchange and control patients
| Control patients | PEX patients | |
|---|---|---|
| Age (years) | 57 (49‐66) | 53 (45‐60) |
| Gender | M:F = 6:7 | M:F = 3:4 |
| Ethnicity |
Caucasian: 5 South‐ Asian: 2 |
Caucasian: 3 East‐ Asian: 1 Middle‐Eastern: 2 African: 1 |
| Weight (kg) | 80 (77‐92) | 79 (76‐99) |
| Symptoms to hospital admission (days) | 7 (4‐11) | 9 (6‐11) |
| Baseline biochemistry | ||
| CRP (mg/L) | 230 (203‐335) | 300 (128‐349) |
| Lymphocyte (/109) | 0.9 (0.6‐1.0) | 0.91 (0.53‐1.10) |
| Creatinine (μmol/L) | 64 (62‐84) | 54 (42‐68) |
| PaO2:FiO2 ratio (mm Hg) | 119 (82‐127) | 87 (81‐148) |
| Mechanical ventilation during time of PEX | 6 of 7 (86%) | 6 of 7 (86%) |
A comparison of the demographic features between those patients who received 5 days of PEX and comparable control patients on the intensive care unit at this time.
Continuous data represent median and interquartile range.